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Background: The purpose of this research was review the epidemiology of the association of 
obesity and urinary incontinence, and to summarize the published data on the effect of weight 
loss on urinary incontinence.
Methods: A literature review of the association between urinary incontinence and overweight/
obesity in women was performed. Case series and clinical trials reporting the effect of surgical, 
behavioral, and/or pharmacological weight loss on urinary incontinence are summarized.
Results: Epidemiological studies demonstrate that obesity is a strong and independent risk 
factor for prevalent and incident urinary incontinence. There is a clear dose-response effect 
of weight on urinary incontinence, with each 5-unit increase in body mass index associated 
with a 20%–70% increase in risk of urinary incontinence. The maximum effect of weight on 
urinary incontinence has an odds ratio of 4–5. The odds of incident urinary incontinence over 
5–10 years increase by approximately 30%–60% for each 5-unit increase in body mass index. 
There appears to be a stronger association between increasing weight and prevalent and incident 
stress incontinence (including mixed incontinence) than for urge incontinence. Weight loss 
studies indicate that both surgical and nonsurgical weight loss leads to significant improvements 
in prevalence, frequency, and/or symptoms of urinary incontinence.
Conclusion: Epidemiological studies document overweight and obesity as important risk 
factors for urinary incontinence. Weight loss by both surgical and more conservative approaches 
is effective in reducing urinary incontinence symptoms and should be strongly considered as a 
first line treatment for overweight and obese women with urinary incontinence.
Keywords: urinary incontinence, obesity, women
Introduction
Urinary incontinence affects almost 50% of middle-aged and older women,1,2 including 
approximately 18.3 million women currently in the US, with an estimated increase to 
28.4 million women by 2050 as our population increases and ages.3 Urinary incontinence 
is associated with a profound adverse effect on quality of life4,5 and accounts for more than 
$30 billion in annual direct costs in the US.6 Risk factors for urinary incontinence include 
aging, childbirth, diabetes, and increased body mass index (BMI).7
More than 50% of American women are overweight (BMI: 25–29.9 kg/m2) or 
obese (BMI: $30 kg/m2), and the prevalence of obesity is increasing by almost 6% 
per year.8 Obesity directly contributes to more than 300,000 deaths per year, accounts 
for expenditure of more than US$100 billion per year, is associated with medical 
comorbidities including heart disease, hypertension, diabetes, cancer, and depression, 
and adversely affects quality of life.8,9
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Obesity is a potentially modifiable risk factor for developing 
urinary incontinence, with numerous epidemiological studies 
suggesting that obesity is a strong risk factor.10–13 Each 5-unit 
increase in BMI is associated with a 60% increase in risk of 
daily incontinence, and obesity has the largest attributable 
risk for daily incontinence compared with other risk factors.13 
Recent data from observational studies and randomized 
clinical trials demonstrate that weight reduction decreases the 
frequency of urinary incontinence episodes among overweight 
and obese women.14 Thus, weight loss represents a promising 
new approach to treatment of urinary incontinence, and one that 
produces a cascade of broader health improvements in addition 
to reductions in the frequency of urinary incontinence.
Methods
We systematically searched for published community-based 
prevalence studies with bivariate or multivariate analysis of 
the association between urinary incontinence and overweight/
obesity in women. Prospective case series, longitudinal stud-
ies, and randomized, controlled trials of the effect of surgi-
cal, behavioral, and pharmacological weight loss on urinary 
incontinence are summarized. Methods were similar to those 
described in a recent systematic literature review.15 Systematic 
searches were done using MEdLInE (1966 and thereafter), 
the Cochrane Central Register of Controlled Trials, the 
Cochrane database of Systematic Reviews, and the database 
of Abstracts of Reviews of Effects. Searches were updated, 
thereby including evidence published up to April 2011.
Association of weight and urinary 
incontinence
Observational epidemiological evidence
Epidemiological studies demonstrate that obesity is a strong risk 
factor for urinary incontinence. A recent systematic literature 
review examined the association between urinary incontinence 
and overweight/obesity in women.15 While the definition of 
urinary incontinence varies according to the study, data from 
a large number of studies indicate that urinary incontinence in 
women is associated with higher BMI and weight.10,13,16–29 Most 
studies demonstrate a clear dose-response effect of weight on 
the prevalence of urinary incontinence,15,16 with odds ratios 
(OR) of 4–5 for the maximum effect of weight on urinary 
incontinence (Figure 1). A stronger association is reported 
between increasing weight and stress-predominant incontinence 
(including mixed incontinence), than for urge-predominant 
incontinence.12,16,22,27,30 Each 5-unit increase in BMI is associated 
with an approximately 20%–70% increase in risk of daily inco
ntinence10,12,13,17,22,25,26 and, in one study, obesity had the largest 
attributable risk for daily incontinence compared with other risk 
factors.13 Among very obese women planning weight reduction 
surgery (BMI . 40 kg/m2), the prevalence of incontinence has 
been reported as  60%–70%,31–35 with the prevalence of pure 
stress incontinence in the range of 28%–33%, pure urge incon-
tinence 4%–21%, and mixed incontinence 32%–46%.31,34
Longitudinal studies
Overweight and obesity have been associated with new 
onset or incident urinary incontinence in population-based, 
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Figure 1 The association between body mass index (BMi) and prevalent urinary 
incontinence (Ui) by type, adjusted for age, parity, coughing and dyspnea. values 
are expressed as odds ratios. Data from Hannestad et al.16 A) Any incontinence. 
B) Severe incontinence.
Reprinted from Journal of Urology, 182(6 Suppl), Subak LL, Richter He, and 
Hunskaar S, Obesity and Urinary incontinence: epidemiology and Clinical Research 
Update, S2–S7, 2009, © with permission from elsevier.14
Open Access Journal of Urology 2011:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
125
Weight loss and urinary incontinence in women
 longitudinal cohort studies. Over 5–10 years of follow-up, 
the odds of incident urinary incontinence increase by 
approximately 7%–12% for each 1 kg/m2 unit increase in 
BMI.36,37 The association of incident urinary incontinence 
with increasing weight is strongest for stress and mixed 
incontinence and weaker for urge incontinence, and provides 
evidence for a temporal relationship between a possible cause 
and an outcome.
A prospective cohort study of women (n = 6424) from the 
UK observed a strong association of BMI with the onset of 
stress incontinence (OR for overweight and obesity 1.4 and 
2.3, respectively) and overactive bladder (OR for overweight 
and obesity 1.3 and 1.2, respectively), with only the trend for 
stress incontinence reaching statistical significance.38,39 In a 
community-based population of women $ 50 years with urge 
urinary incontinence participating in the Health and Retire-
ment Study, predictors of incident urge urinary incontinence 
included obesity (OR: 1.6, 95% confidence interval [CI]: 
1.2–2.1).40 In a 5-year annual follow-up of 3301 women aged 
42–52 years, incident incontinence was found in 56%, for 
an annual incidence of 11% per year.36 Multivariate analyses 
showed that each unit of BMI was associated with any (OR: 
1.05, 95% CI: 1.02–1.07), frequent (OR: 1.12, 95% CI: 
1.06–1.19), stress (OR: 1.06, 95% CI: 1.03–1.10), urgency 
(OR: 1.03, 95% CI: 1.01–1.06), and mixed (OR: 1.09, 95% 
CI: 1.04–1.13) urinary incontinence. In the nurses’ Health 
Study II (n = 35,754), increasing BMI was associated with 
higher odds of incident urinary incontinence.37 Comparing 
women with BMI $ 35, in those with BMI 21.0–22.9, the 
OR for at least monthly urinary incontinence was 2.11 (95% 
CI: 1.84–2.42), at least weekly urinary incontinence 3.85 
(95% CI: 3.05–4.85), and severe urinary incontinence 5.52 
(95% CI: 3.72–8.18).
Weight gain and incident urinary 
incontinence
The odds of incident urinary incontinence also increase 
with increasing adult weight gain.37 Compared with women 
who maintained their weight within 2 kg, the OR for at 
least weekly incontinence was 1.44 (95% CI: 1.05–1.97) 
among women who gained 5.1–10.0 kg and 4.04 (95% CI: 
2.93–5.56) among women who gained more than 30 kg since 
early adulthood (P, 0.001 for trend). Compared with women 
having a BMI of 21.0–22.9, women with BMI $ 35 had an 
OR for stress incontinence of 3.42 (95% CI: 2.48–4.72), 6.10 
for urge incontinence (95% CI: 3.11–11.98), and 5.60 for 
mixed incontinence (95% CI: 3.17–9.88). In a longitudinal 
study of 1201 British women, high BMI at age 20–36 years 
was associated with stress urinary incontinence and severe 
urinary incontinence in midlife. Longstanding overweight 
was a stronger predictor than becoming overweight/obese 
after the age of 43 years (OR: 1.85, 95% CI: 0.97–3.51).29
Body fat distribution and urinary 
incontinence
Little is known about the association of fat distribution, 
for example, abdominal adiposity estimated by waist cir-
cumference or waist-hip ratio, with urinary incontinence. 
In multivariable analyses including BMI, increasing waist-
hip ratio has been found to be an independent risk factor 
for stress incontinence (OR: 1.18 per 0.1 unit), but not for 
urge and mixed incontinence.12 Among a cohort of Korean 
women, compared with women in the lowest quartile of waist 
circumference, the ORs for stress incontinence increased 
significantly in a dose-dependent relationship (1.79, 3.50, 
and 6.07 for the next quartiles, respectively) after adjustments 
for BMI.21 Among women in the nurses’ Health Study, there 
were highly significant trends of increasing risk of inconti-
nence with both increasing BMI and waist circumference.41 
When BMI and waist circumference were included in 
models simultaneously, BMI was associated with urgency 
and mixed incontinence, but not stress incontinence. Waist 
circumference was associated only with stress incontinence. 
In the EPInCOnT study of 6876 incontinent norwegian 
women, multivariable analyses adjusting for age, parity, and 
BMI showed a statistically significant association between 
waist-hip ratio and any incontinence and mixed incontinence 
(both OR: 1.1 per 0.1 unit).42 In the American Boston Area 
Community Health survey, each 10-cm increase in waist 
circumference in women was independently associated with 
higher prevalence of weekly urinary incontinence (OR: 1.15, 
95% CI: 1.01–1.31).43
Treatment options for urinary 
incontinence
The mainstay of treatment for both stress and urge urinary 
incontinence is bladder training, toileting assistance, and/or 
pelvic muscle rehabilitation.44–46 These behavioral approaches 
are only modestly effective, and in many cases, a second 
line of therapy is needed. Second-line treatment for stress 
incontinence is frequently surgical. Among 665 women 
enrolled in a clinical trial of the Burch and pubovaginal sling 
procedures, objective stress incontinence cure rates decreased 
from almost 100% after surgery to 50%–65% over 2 years.47 
In a randomized equivalence trial of 597 women with stress 
incontinence assigned to either retropubic or transobturator 
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midurethral slings, the rates of objective treatment success at 
12 months were 80% in the retropubic sling group and 77% 
in the transobturator sling group.48 Although surgery is effec-
tive, it is associated with discomfort and a prolonged recovery 
period, and incontinence may recur over time.49,50 Concerns 
about higher rates of failure and operative complications in 
obese women have led to debate about the role of surgery 
in this population, although the safety and effectiveness of 
continence surgery in obese women has been supported by 
the literature.51–57 In addition, many women prefer not to 
have surgery, and others, particularly obese women, are poor 
surgical candidates. Pharmacological therapy, primarily with 
anticholinergic or antimuscarinic medications, is frequently 
the second line of therapy for urge urinary incontinence 
and results in a 15%–60% reduction in weekly incontinent 
episodes. However, anticholinergic side effects are common 
and the medications must be taken chronically.58–61 newer 
medications and reformulations of older drugs provide bet-
ter tolerability, but long-term compliance remains low.62,63 
Approved implantable neurostimulator devices and sacral 
neuromodulation and intravesical botulinum toxin type A 
injection represent newer alternatives for the management 
of refractory urge urinary incontinence that have been used 
with success, but are more invasive and costly,64–66 and in 
the case of the latter, not yet approved by the Food and drug 
Administration. new and novel treatment strategies for 
urinary incontinence are important to improve efficacy and 
provide acceptable therapeutic options for women.
Effect of weight loss on urinary 
incontinence
Because obesity is a potentially modifiable risk factor for 
urinary incontinence, weight reduction has been shown 
to be an effective treatment option. A beneficial effect of 
weight loss on the prevalence and frequency of incontinence 
has been found in surgical and behavioral weight reduction 
interventions (Table 1).14,15
Surgical weight loss
In observational studies, severely obese women (.45 kg 
above ideal weight) with incontinence who had dramatic 
weight loss after bariatric surgery (45–50 kg) had significant 
improvement in urinary incontinence.32,67,68 In one study 
(n = 138), the prevalence of stress urinary incontinence 
decreased from 61% at baseline to 12% (P, 0.001) after 
stabilization of weight over 2–5 years,32 and in a second study 
(n = 101), the prevalence of any incontinence decreased from 
67% at baseline to 37% at 12 months (P, 0.001).31 In another 
surgical cohort undergoing bariatric surgery, the prevalence 
of pelvic floor disorder symptoms including urinary incon-
tinence improved from 87% before surgery to 65% after 
surgery.35 In a morbidly obese cohort undergoing bariatric 
surgery with an average weight loss of 49 kg, there was a 
significant improvement in stress incontinence (P, 0.001), 
frequency and leakage of any degree, and overall quality 
of life subsequent to surgery.69 In a cohort of 253 morbidly 
obese patients undergoing laparoscopic sleeve gastrectomy, 
stress urinary incontinence was reported preoperatively in 
60 (32%) females, and complete resolution or improve-
ment was reported in 54 (90%) patients.70 Statistically 
significant changes have also been observed in urodynamic 
parameters,68,71 frequency of incontinence episodes, and the 
need to use absorptive pads.67
Behavioral weight loss
decreased frequency of urinary incontinence episodes has 
also been observed following enrollment in behavioral 
weight loss programs, including very low calorie liquid diet 
and intensive lifestyle diet and exercise interventions.71–74 
In a small prospective cohort study of overweight and obese 
incontinent women enrolled in very low calorie liquid diet 
weight reduction programs, six of six women achieving a 
weight loss of $5% had at least a 50% reduction in frequency 
of urinary incontinence compared with one of four women 
with ,5% weight loss (P = 0.03).71 A randomized trial of a 
3-month, very low calorie liquid diet program compared with 
no intervention (n = 42) found greater weight loss among 
women randomized to the diet interventioncompared with 
controls (14 kg vs 0 kg) and a greater decrease in weekly 
frequency of incontinence episodes from baseline (60% vs 
15%; P, 0.001), with decreases observed in both stress 
(P = 0.003) and urge (P = 0.03) incontinent episodes.72 The 
weight and urinary incontinence decreases were maintained 
for 6 months.
Overweight prediabetic women enrolled in the diabetes 
Prevention Program (n = 1957) were randomized to intensive 
lifestyle therapy, metformin, or placebo with standard lifestyle 
advice.73 At almost 3 years of follow-up, the prevalence of total 
weekly incontinence was lower among women in the intensive 
lifestyle group (38%) than those randomized to metformin 
(48%) or placebo (46%; P, 0.001). This difference was most 
apparent among women with stress incontinence (31% for 
intensive lifestyle group vs 40% for metformin vs 37% for 
placebo, P = 0.006). Change in weight accounted for almost 
all of the incontinence effect explained (35%), with change in 
exercise and incident diabetes each explaining only 5%.
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Table 1 The effects of weight loss on urinary incontinence
Study N Design, f/u Change in BMI  
(or wt)‡
Change in prevalent  
UI or UI episodes†
Other outcomes
Case series and cohort studies of surgical weight loss
Deitel  
et al32
138 Unknown 124 to 79 kg 61% to 12%, prevalent  
stress Ui (P , 0.001)
infertility and menstrual 
irregularities improved
Bump  
et al67
13 12 months BMi: 49 to 33  
(132 to 88 kg)
92% to 23% prevalent  
Ui (P = 0.004)
Differences seen in: 
– urodynamic parameters 
– urethral mobility
Sugerman  
et al68
15 12 months BMi: 52 to 33  
(140 to 87 kg)
47% to 0% prevalent  
Ui (P , 0.001)
Significant changes in: 
–  sagittal abdominal diameter 
(32 to 20 cm, P , 0.0001 )
–  urinary bladder pressure  
(17 to 10 cm H2O, P , 0.001)
Frigg  
et al100
233 44 months excess wt loss at  
4 year f/u was 54%
26% to 11% prevalent  
stress Ui at 2 years f/u
improvements in other medical 
comorbidities
Burgio  
et al31
101 12 months BMi: 49 to 30 67% to 37% (P , 0.001) –  Fi prevalence decreased, 19% 
to 9% (P = 0.018)
–  Decrease in UI significantly 
associated with BMi
vella  
et al69
126 20 months BMi: 47.5 to 31 improvement in stress  
incontinence (45% to 20%),  
frequency and leakage  
of any degree
improvement in overall quality 
of life
Srinivasa  
et al70
171 12 months 41 kg, mean excess  
BMi loss 59%
Stress Ui preoperatively  
in 60 (32%), complete  
resolution or improvement  
was reported in 54  
(90%) patients
Cohort studies and randomized trials of nonsurgical weight loss on UI
Subak  
et al71
10 Cohort: very  
low calorie  
liquid diet  
wt loss program
3 month f/u
BMi: mean 38 to 33  
(–14 kg; P , 0.03)
13 to 8 Ui episodes  
per week after wt loss  
(P , 0.07)
All women losing $5% body wt 
(6 of 10) had .50% reduction in 
Ui frequency (P , 0.03)
Subak  
et al72
40 Randomized to:
1.  very low calorie  
liquid diet  
(n = 20)
2.  Control  
(n = 20)
3  month intervention,  
9 month f/u
Wt change by group  
(3 months):
1. −16 kg
2. No change
P , 0.0001
Reduction in weekly  
Ui episodes (3 months):
1. 60%
2. 15%
P , 0.0005
–  Stress (P = 0.003) and urge  
(P = 0.03) Ui episode 
frequency decreased in Group 
1 vs Group 2
–  Group 2 had the intervention 
after 3 months: 71% reduction 
in weekly Ui after wt loss
–  Significant improvement in IIQ 
and UDi scores after wt loss
Brown  
et al73
1957 Randomized to:
1.  Lifestyle intervention*  
(n = 660)
2.  Metformin  
(n = 636)
3.  Placebo (n = 661) 
2.9 years mean f/u
Wt change by group:
1. −3.4 kg
2. −1.5 kg
3. +0.5 kg
P , 0.001
Prevalence of weekly Ui:
1. 38% 
2. 48%
3. 46%
P = 0.001
–  Weekly stress Ui was lower 
in Group 1 (31% vs 40% in 
Group in 2 and 37% in  
Group 3; P = 0.006)
–  No difference in prevalent 
urge Ui by randomized group 
(24%, 29%, 26% for groups 1, 
2, and 3; P = 0.12)
Auwad  
et al75
64 Cohort: low calorie  
diet, exercise, Orlistat  
(N = 40).
included 42 (65%)  
women with $5%  
wt loss in analyses
BMi: median  
36.2 to 31.9  
(8.8 kg) at  
18 months
24-hour pad test wt  
median 38.8 to 18.5 gm  
(P , 0.001)
After $5% wt loss, decrease in 
nocturia, bladder neck mobility, 
and all domains of the Kings 
Health Questionnaire  
(all P , 0.05).
(Continued)
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Table 1 (Continued)
Study N Design, f/u Change in BMI  
(or wt)‡
Change in prevalent  
UI or UI episodes†
Other outcomes
Subak et al74 
Wing et al76
338 Randomized to:
1.  6 month lifestyle 
intervention, 12 month 
maintenance*  
(n = 226)
2.  Structured education 
program (n = 112) 
18 month f/u
6 months:
Wt change by group:
1. −7.8 kg (8%)
2. −1.5 kg (1.6%)
P , 0.001
Reduction in weekly  
total Ui/stress Ui:
1. 47%/58%
2. 28%/33%
P = 0.01/,0.02
Higher proportion of Group 1 
vs Group 2 had:
–  $70% reduction in frequency 
of all (P , 0.001), stress  
(P = 0.009) and urge (P = 0.04) 
Ui episodes
–  greater perceived 
improvement Ui frequency, 
lower volume of urine lost, 
Ui as a less of a problem, and 
higher satisfaction with the 
change in their Ui  
(all P , 0.001)
18 months:
Wt change by group:
1. −5.5%
2. −1.6%
P , 0.001
$70% reduction in  
frequency of urge  
Ui episodes:
1. 47%/34%
P = 0.03
Higher proportion of Group 1 
vs Group 2 had:
–  greater perceived lower 
volume of urine lost, Ui as a 
less of a problem, and higher 
satisfaction with the change in 
their Ui (all P , 0.05)
Notes: *Lifestyle intervention included diet, exercise, and behavior modification program; ‡Mean change unless otherwise specified; †Percent change.
Abbreviations: UI, urinary incontinence; FI, fecal incontinence; UDI, Urogenital Distress Inventory; IIQ, Incontinence Impact Questionnaire; f/u, follow-up; wt, weight.
Reprinted from Journal of Urology, 182(6 Suppl), Subak LL, Richter He, and Hunskaar S, Obesity and Urinary incontinence: epidemiology and Clinical Research Update, 
S2–S7, 2009, © with permission from elsevier.14
In a prospective longitudinal study of 64 obese women 
with urodynamic stress urinary incontinence participating 
in a low calorie diet and exercise program with addition of 
orlistat, the antiobesity drug, offered to those who did not 
achieve a target loss of 5%–10%, weight loss of at least 5% 
was associated with significant reduction in pad test loss 
(median difference, 19 g; 95% CI: 13–28 g; P , 0.001). There 
was also a clinical and statistically significant improvement 
in quality of life measures.75
The first large randomized trial on the effect of weight 
reduction on urinary incontinence included 338 overweight 
and obese women with at least ten urinary incontinence epi-
sodes per week randomized to an intensive 6-month weight 
loss program (diet, exercise, and behavior modification, 
n = 226) or to a structured education program (n = 112).74 
After 6 months, women in the intervention group achieved 
a mean weight loss of 8% compared with 2% in the con-
trol group (P , 0.0001), and the mean number of weekly 
incontinence episodes decreased by 47% in the intervention 
group compared with 28% in the control group (P = 0.01). 
As compared with the control group, the intervention group 
had a greater decrease in the frequency of stress inconti-
nence episodes (P = 0.02), but not of urge incontinence 
episodes (P = 0.14). At 12 months, the intervention group 
reported a greater percent reduction in weekly stress urinary 
incontinence episodes (65% vs 47%, P , 0.001) and a greater 
proportion achieved at least a 70% decrease in weekly total 
and stress urinary incontinence episodes compared with 
controls. By 18 months, a greater proportion of women in 
the intervention group had at least a 70% improvement in 
urge incontinence episodes, but there were no significant 
differences between the groups for stress or total urinary 
incontinence. The intervention group also reported greater 
satisfaction with changes in urinary incontinence than the 
control group at 6, 12, and 18 months.76
Mechanism of the obesity–
incontinence association
While the mechanism of the obesity–urinary incontinence 
association is unknown, it is theorized that excess body weight 
increases abdominal pressure, which in turn increases blad-
der pressure and urethral mobility, leading to stress urinary 
incontinence, and also exacerbates detrusor instability and 
overactive bladder.67,72 Although a mechanical mechanism has 
been proposed for stress urinary incontinence in overweight 
and obese women, an inflammatory response in the urinary 
bladder has been proposed for overactive bladder. Elevated 
levels of urine biomarkers involved in inflammation and tissue 
repair have suggested a role for inflammation in overactive 
bladder.77 Obesity induced by diet has also been shown to be 
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associated with macrophage infiltration into adipose tissue,78 
a process which has been proposed to affect adipocytes sur-
rounding the human bladder, leading to inflammation and 
overactive bladder symptoms.79 The underlying mechanism 
may also be related to lower levels of circulating ghrelin 
levels associated with obesity that adversely affect urethral 
support and detrusor contractility.79–81 Comorbid diabetes 
mellitus, closely linked to obesity, is also a risk factor for 
both stress and urge urinary incontinence in obese women;14,30 
the microvascular compromise induced by diabetes in obese 
women may adversely affect the continence mechanism or 
bladder “sensitivity”.79 Additionally, obesity, like pregnancy, 
may cause chronic strain, stretching and weakening of the 
muscles, nerves, and other structures of the pelvic floor that 
may lead to dysfunction of the continence mechanism, and 
place obese women at risk for incontinence.82,83
Strong associations between BMI and intra-abdominal 
pressure (Pearson’s coefficient correlation 0.76) and intra-
vesical pressure (Pearson’s coefficient correlation 0.71) have 
been observed.84 In addition, weight loss is associated with 
changes in urodynamic parameters. Following large, surgi-
cally induced weight loss, statistically significant changes 
have been reported in urodynamic parameters, including 
decreased intravesical pressure, magnitude of bladder pres-
sure increases with coughing, bladder-to-urethra pressure 
transmission with cough, and urethral axial mobility,67,68 
supporting the theory of increased abdominal pressure. 
With moderate weight loss (13% of baseline weight), sig-
nificant correlations between weight change and decreased 
initial intravesical pressure (Spearman’s r = 0.52, P = 0.01), 
decreased intravesical pressure at maximum capacity 
(r = 0.62, P = 0.001) and increased Valsalva leak point 
pressure (r = 0.57, P = 0.03) have been observed.72 In a 
study aimed at describing the urodynamic characteristics 
of overweight and obese women with urinary incontinence 
participating in the Program to Reduce Incontinence by diet 
and Exercise (PRIdE), intra-abdominal pressure at maximum 
cystometric capacity increased 0.4 cm H
2
O per kg/m2 unit of 
BMI and 0.4 cm H
2
O per 2 cm increase in abdominal circum-
ference, and intravesical pressure at maximum cystometric 
capacity increased 0.4 cm H
2
O per 2-cm increase in abdomi-
nal circumference, but was not associated with BMI.85
Patient-focused perspectives
Urinary incontinence has been associated with a profound 
adverse effect on overall and health-related quality of life,86,87 
a 20%–30% increased risk of falls and fractures,88,89 and dra-
matic limitations in daily functioning.2,4,5,90–93 In a systematic 
review of the literature on quality of life among women 
with urinary incontinence, factors influencing quality of life 
were age, severity of urinary incontinence, type of urinary 
incontinence, frequency of urinary incontinence episodes, 
body weight, stress, and help-seeking behavior.91 In a cross-
sectional study of 5530 eligible respondents to a mail survey, 
one of the strongest predictors of urinary incontinence was 
obesity, and urinary incontinence had a stronger influence on 
quality of life than diabetes, cancer, and arthritis.94
Although there are many studies quantifying the effect 
of incontinence on general and incontinence-specific quality 
of life using instruments like the Short Form (SF-36) Health 
Survey95 and Incontinence Impact Questionnaire,96 respec-
tively, there are few data on the impact of urinary incontinence 
on health-related quality of life measured by health utilities 
instruments, an important outcome for cost-utility analyses. 
Incontinence, Alzheimer’s disease, and stroke are self-assessed 
as the three chronic health conditions that most adversely 
affect women’s health-related quality of life.6,97,98 In addition, 
obesity itself is associated with increased risk for coronary 
heart disease, hypertension, diabetes, cancer, dyslipidemia, 
stroke, liver or gallbladder disease, sleep apnea and respiratory 
disease, osteoarthritis, and depression.9,99 Thus, women who 
are both overweight and incontinent are at tremendous risk for 
negative health outcomes and impaired quality of life.
In the PRIdE study,74 several patient-focused perspec-
tives were assessed. Women in the weight loss group per-
ceived greater improvement in the frequency of their urinary 
incontinence, lower volume of urine lost, incontinence as a 
less of a problem, and higher satisfaction with the change in 
their incontinence at 6 months compared with women in the 
control group (P , 0.001) at 6 months74 and 18 months.76 
Therefore, weight loss, a treatment approach that can impact 
both incontinence and obesity, is an exciting new treatment 
direction for this population and has tremendous implications 
for general and health-related quality of life.
Conclusion
Epidemiological studies demonstrate that obesity is a 
strong, independent, and modifiable risk factor for prevalent 
and incident urinary incontinence. There is a clear dose-
response effect of weight on prevalent and incident urinary 
incontinence. There appears to be a stronger association 
between increasing weight and prevalent and incident stress 
incontinence (including mixed incontinence) than for urge 
incontinence and overactive bladder syndrome. However, the 
precise mechanism of the association between obesity and 
incontinence is unknown, and additional  neurophysiologic 
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and urodynamic studies are needed to define better the 
obesity–urinary incontinence relationship.
Weight loss studies indicate that both surgical and non-
surgical weight loss leads to significant improvements in 
urinary incontinence symptoms. data support that weight 
loss of 5%–10% has an efficacy similar to that of other 
nonsurgical urinary incontinence treatments and should be 
strongly considered as a first-line therapy for incontinence. 
In addition, moderate weight reduction is associated with 
extensive health improvements.
Future directions
High priorities for future research include well designed 
observational studies and intervention trials to examine the 
effectiveness of weight loss for urinary incontinence in a gen-
eral population of overweight and obese women with urinary 
incontinence; assess the comparative effectiveness of standard 
surgical, pharmacological, and behavioral urinary inconti-
nence treatments in overweight and obese women; evaluate if 
healthier lifestyle choices, such as weight control and physical 
activity, are effective to prevent the onset or worsening of uri-
nary incontinence in women; explore the mechanisms of how 
weight affects urinary incontinence and weight loss improves 
urinary incontinence; and, examine the role of adipocytokines, 
inflammation or other biologically active substances in the 
weight-urinary incontinence association. In addition, measures 
of urinary incontinence could be included in studies of weight 
loss and behavioral/lifestyle interventions to document further 
the effect of these interventions on urinary incontinence, bet-
ter characterize women likely to benefit from weight loss, 
and determine if urinary incontinence improvements can be 
sustained with long-term weight reduction.
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